Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly.

The clearance brings an oral form of Novo’s Wegovy to market ahead of Lilly’s rival medication and kicks off the next phase ...

The global GLP-1 market has been in the spotlight for the past couple of years as big pharma players realize its multi-billion-dollar potential and the untapped nature. It is currently dominated by ...

Four trend wars, four surprising winners. Dive into the food and beverage battles that dominated the industry in 2025 ...

The Food and Drug Administration's approval of a Wegovy pill, the first ever oral GLP-1 medication on Dec. 22, underscores an increasing demand for weight loss drugs across the U.S.

Eli Lilly's GLP-1 drug is now the world's best-selling drug. Novo Nordisk is struggling with declining market share. Pfizer is desperately trying to get into the GLP-1 game. 10 stocks we like better ...

GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity or overweight with a related health condition. Read on for everything you need to know about GLP-1s for weight loss, ...

Explore the biggest food and beverage trend battles of 2026 — from protein vs fibre to GLP‑1 drugs vs satiety‑boosting foods ...

GLP-1 usage is on the rise, and researchers are looking for other health benefits associated with the drug, including its effects on bladder health. But as GLP-1s rise in popularity, so do nicknames ...

Dr. Jennah Siwak breaks down the factors she and her patients weigh when deciding if GLP-1 medications are the right fit. Glucagon-like peptide-1 (GLP-1) medications, which mimic a natural gut hormone ...